Applications

Conventional cancer models often fail to capture the complexity of the tumor microenvironment, leading to poor translation from lab to clinic. Our organ-on-chip technology creates dynamic systems that more closely resemble human biology, enabling researchers to generate insights and results that conventional approaches miss.

Every patient is unique, yet conventional models often overlook this individuality. By integrating patient-derived cells and organoids into our organ-on-chip systems, we enable personalized testing that predicts individual drug responses and supports tailored therapy selection.

Ineffective preclinical models can slow drug development and increase costs. Our organ-on-chip solutions bring human relevance into the early stages of discovery, supporting more informed decisions and accelerating the path toward clinical validation.

With our platform, you can assess compound safety in human-relevant models, detect organ-specific toxicity, and capture both acute and long-term exposure effects that conventional systems often miss.

With our platform, you can model metabolic cross-talk between organs, link microbiota activity to host responses, and generate reproducible data that accelerates the development of new therapies for metabolic disorders.

The human microbiome is vital for health and therapy response, yet hard to model with traditional tools. With our platform, you can create gut-like environments — with flow, oxygen control, and hypoxia — and extend them to other tissue–microbe systems for deeper insights.

Extracellular vesicles are emerging as key mediators of cell-to-cell communication in health and disease. With our platform, you can study EV-mediated signaling in controlled microenvironments and explore their role in disease mechanisms and therapeutic development.

Understanding immune responses requires models that capture the complexity of human biology. Our organ-on-chip technology provides a controlled environment to study immune cell behavior, barrier function, and cytokine signaling — supporting the development of next-generation therapies.